Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-12-19 Purchase |
2024-12-19 6:42 pm |
Vigil Neuroscience Inc. | VIGL | Magovcevic-Liebisch Ivana President and CEO |
5,000 | $1.68 | $8,400 | 222,687 (Direct) |
View |
| 2024-12-18 Purchase |
2024-12-18 5:51 pm |
Vigil Neuroscience Inc. | VIGL | Magovcevic-Liebisch Ivana President and CEO |
5,000 | $1.67 | $8,350 | 217,687 (Direct) |
View |
| 2024-12-05 Purchase |
2024-12-05 5:09 pm |
Vigil Neuroscience Inc. | VIGL | Magovcevic-Liebisch Ivana President and CEO |
5,000 | $2.34 | $11,700 | 212,687 (Direct) |
View |
| 2023-11-20 Purchase |
2023-11-20 6:34 pm |
Vigil Neuroscience Inc. | VIGL | Magovcevic-Liebisch Ivana President and CEO |
4,000 | $3.75 | $15,000 | 207,687 (Direct) |
View |
| 2022-05-02 Purchase |
2022-05-04 07:00 am |
Vigil Neuroscience Inc. | VIGL | Magovcevic-Liebisch Ivana President and CEO |
5,000 | $3.6758 | $18,379 | 203,687 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-03 Option Award |
2025-03-04 5:08 pm |
N/A 2035-03-03 |
Vigil Neuroscience Inc. | VIGL | Magovcevic-Liebisch Ivana President and CEO |
485,000 | $0 | 485,000 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-06 5:57 pm |
2025-12-31 2035-01-02 |
Quanterix Corp | QTRX | Magovcevic-Liebisch Ivana Director |
23,256 | $0 | 36,056 (Direct) |
View |
| 2024-10-02 Option Award |
2024-10-03 5:17 pm |
N/A 2034-10-02 |
Quanterix Corp | QTRX | Magovcevic-Liebisch Ivana Director |
40,489 | $0 | 40,489 (Direct) |
View |
| 2024-05-03 Option Award |
2024-05-07 5:00 pm |
N/A 2032-03-01 |
Vigil Neuroscience Inc. | VIGL | Magovcevic-Liebisch Ivana President and CEO |
652,000 | $0 | 652,000 (Direct) |
View |
| 2024-03-01 Option Award |
2024-03-01 5:53 pm |
N/A 2034-03-01 |
Vigil Neuroscience Inc. | VIGL | Magovcevic-Liebisch Ivana President and CEO |
463,000 | $0 | 463,000 (Direct) |
View |
| 2024-02-08 Option Award |
2024-02-09 4:37 pm |
N/A 2034-02-07 |
Acrivon Therapeutics Inc. | ACRV | Magovcevic-Liebisch Ivana Director |
32,500 | $0 | 32,500 (Direct) |
View |
| 2023-06-22 Option Award |
2023-06-30 4:32 pm |
N/A 2033-06-22 |
Aeglea BioTherapeutics Inc. | AGLE | Magovcevic-Liebisch Ivana Director |
1,950,000 | $0 | 1,950,000 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 5:14 pm |
N/A 2033-03-01 |
Vigil Neuroscience Inc. | VIGL | Magovcevic-Liebisch Ivana President and CEO |
370,000 | $0 | 370,000 (Direct) |
View |
| 2022-06-08 Option Award |
2022-06-10 4:50 pm |
N/A 2032-06-07 |
Absci Corp | ABSI | Magovcevic-Liebisch Ivana Director |
28,700 | $0 | 28,700 (Direct) |
View |
| 2022-06-07 Option Award |
2022-06-09 9:17 pm |
N/A 2032-06-06 |
Aeglea BioTherapeutics Inc. | AGLE | Magovcevic-Liebisch Ivana Director |
43,000 | $0 | 43,000 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-03 4:06 pm |
N/A 2032-03-01 |
Vigil Neuroscience Inc. | VIGL | Magovcevic-Liebisch Ivana President and CEO |
282,000 | $0 | 282,000 (Direct) |
View |
Ownership |
2022-01-06 8:34 pm |
N/A N/A |
Vigil Neuroscience Inc. | VIGL | Magovcevic-Liebisch Ivana President and CEO |
0 | $0 | 1,227,432 (Direct) |
View |
| 2021-11-30 Option Award |
2021-12-02 6:55 pm |
N/A 2031-11-30 |
APPLIED GENETIC TECHNOLOGIES CORP | AGTC | Magovcevic-Liebisch Ivana Director |
14,000 | $0 | 14,000 (Direct) |
View |
Ownership |
2021-07-21 8:55 pm |
N/A N/A |
Absci Corp | ABSI | Magovcevic-Liebisch Ivana Director |
0 | $0 | 354,024 (Direct) |
View |
| 2021-06-08 Option Award |
2021-06-09 5:25 pm |
N/A 2031-06-07 |
Aeglea BioTherapeutics Inc. | AGLE | Magovcevic-Liebisch Ivana Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2020-12-16 Option Award |
2020-12-18 5:39 pm |
N/A 2030-12-16 |
APPLIED GENETIC TECHNOLOGIES CORP | AGTC | Magovcevic-Liebisch Ivana Director |
12,000 | $0 | 12,000 (Direct) |
View |
| 2020-06-08 Option Award |
2020-06-10 4:26 pm |
N/A 2030-06-07 |
Aeglea BioTherapeutics Inc. | AGLE | Magovcevic Ivana Director |
28,100 | $0 | 28,100 (Direct) |
View |